RA
MDT icon

Riversedge Advisors’s Medtronic MDT Stock Holding History

Riversedge Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$588K Buy
6,809
+3,204
+89% +$282K 0.07% 125
2026
Q2 		$282K Buy
+3,605
New +$291K 0.04% 219

Other funds holding MDT

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
AMBIA
Allen Mooney & Barnes Investment Advisors Thomasville, Georgia $673M AUM 20.03% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return

Riversedge Advisors's MDT Position: Q3 2026 in Review

Riversedge Advisors increased its Medtronic (MDT) stake by 89% in Q3 2026, buying an estimated $282K and bringing the position to 6,809 shares worth $588K. The position accounts for 0.07% of the portfolio, ranked #125.

Riversedge Advisors first reported a position in MDT in Q2 2026 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Riversedge Advisors held 6,809 shares of Medtronic worth $588K as of Q3 2026.
  • Riversedge Advisors bought 3,204 Medtronic shares in Q3 2026, an estimated $282K.
  • Medtronic made up 0.07% of Riversedge Advisors's portfolio in Q3 2026, its #125 holding.
  • Riversedge Advisors first reported a position in Medtronic in Q2 2026 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.